About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Berlin Deep Brain Stimulation Depression Study

NCT00531726·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Charite University, Berlin, Germany

With

University Hospital Carl Gustav Carus
Ludwig-Maximilians - University of Munich
Hannover Medical School

Age

25–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

patient is diagnosed with a severe major depressive episode
patient is in a chronic current MDE and/or has had a history of recurrent MDEs
patient has not had an acceptable clinical response due to failure with at least three antidepressant treatments during the current episode.
patient has a score \> 20 on the HAMD24
patient is stable on current psychotropic medication for at least 6 weeks
patient is \>25 and \<80 years
Global Assessment of Function (GAF) score of \< 45

You may not be if

Atypical Depression (according to DSM IV)
Other relevant psychiatric axis I or axis II diseases
Relevant neurological diseases
Relevant cardiac or pulmonary diseases with enhances anaesthesiological risk (ASA Score \> 3)
Patient is currently enrolled in another investigational study not associated with the current study
Patient has a history of, or evidence of, significant brain malformation or significant head injury
Patient is likely to require a whole body MRI after implantation

The record

StatusCompleted

PhaseNo phase

Taking part11

StartedSep 2007

UpdatedJan 24, 2018

Conditions

Treatment Resistant Depression

Where1

Charité - Universitaetsmedizin Berlin
Berlin, Germany

Clareo Health | Berlin Deep Brain Stimulation Depression Study